1. Mortazavi SM, Tarinjoo A, Dastani S, Niyazpour M, Dahaghin S, Mirnejad R. Molecular Detection of Sexually Transmitted Infections in Women with and without Human Papillomaviruses Infection Who Referred to Tehran West Hospitals in Iran. Rep Biochem Mol Biol. 2021;10(3):387-395. [
DOI:10.52547/rbmb.10.3.387] [
PMID] [
]
2. Price MJ, Ades AE, Welton NJ, Simms I, Macleod J, Horner PJ. Proportion of Pelvic Inflammatory Disease Cases Caused by Chlamydia trachomatis: Consistent Picture From Different Methods. J Infect Dis. 2016;214(4):617-24. [
DOI:10.1093/infdis/jiw178] [
PMID] [
]
3. Report on global sexually transmitted infection surveillance, 2018. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO.
4. Ohman H, Tiitinen A, Halttunen M, Paavonen J, Surcel HM. Cytokine gene polymorphism and Chlamydia trachomatis-specific immune responses. Hum Immunol. 2011;72(3):278-82. [
DOI:10.1016/j.humimm.2010.12.012] [
PMID]
5. Jukema JB, Hoenderboom BM, van Benthem BHB, van der Sande MAB, de Vries HJC, Hoebe CJPA, et al. Can Previous Associations of Single Nucleotide Polymorphisms in the TLR2, NOD1, CXCR5, and IL10 Genes in the Susceptibility to and Severity of Chlamydia trachomatis Infections Be Confirmed? Pathogens. 2021;10(1):48. [
DOI:10.3390/pathogens10010048] [
PMID] [
]
6. Broeze KA, Opmeer BC, Coppus SF, Van Geloven N, Den Hartog JE, Land JA, et al. Integration of patient characteristics and the results of Chlamydia antibody testing and hysterosalpingography in the diagnosis of tubal pathology: an individual patient data meta-analysis. Hum Reprod. 2012;27(10):2979-90. [
DOI:10.1093/humrep/des281] [
PMID]
7. Datta A, Tuz Zahora F, Abdul Aziz M, Sarowar Uddin M, Ferdous M, Shalahuddin Millat M, et al. Association study of IL10 gene polymorphisms (rs1800872 and rs1800896) with cervical cancer in the Bangladeshi women. Int Immunopharmacol. 2020;89(Pt B):107091. [
DOI:10.1016/j.intimp.2020.107091] [
PMID]
8. Williams AE, Edwards L, Humphreys IR, Snelgrove R, Rae A, Rappuoli R, Hussell T. Innate imprinting by the modified heat-labile toxin of Escherichia coli (LTK63) provides generic protection against lung infectious disease. J Immunol. 2004;173(12):7435-43. [
DOI:10.4049/jimmunol.173.12.7435] [
PMID]
9. Moumad K, Khaali W, Benider A, Ayoub W, Cherif M, Boualga K, et al. The Involvement of Interleukin-10 Promoter Genetic Polymorphism in Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma from North Africa. Eurasian J Med Oncol. 2022; 6(3):232-240.
10. Darville T, O'Neill JM, Andrews CW Jr, Nagarajan UM, Stahl L, Ojcius DM. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J Immunol. 2003;171(11):6187-97. [
DOI:10.4049/jimmunol.171.11.6187] [
PMID]
11. Xiang W, Yu N, Lei A, Li X, Tan S, Huang L, Zhou Z. Insights into Host Cell Cytokines in Chlamydia Infection. Front Immunol. 2021;12:639834. [
DOI:10.3389/fimmu.2021.639834] [
PMID] [
]
12. Wei M, Chen D, Feng G, Mao X, Wu L, Chai W, Zhang J. Association of infertility cause with perinatal outcomes in a freeze-all policy: an analysis including 10,151 singleton newborns. AJOG Glob Rep. 2022;3(1):100098. [
DOI:10.1016/j.xagr.2022.100098] [
PMID] [
]
13. Mohammed MA, Omer AF. Molecular detection of Chlamydia trachomatis among gynecological patients attending Khartoum Teaching Hospital. J Bacteriolo Res. 2012;4(4):42-5. [
DOI:10.5897/JBR12.004]
14. Gahanbarzade N, Ramazani E, Yousefi M, Zardast M, Zare-Bidaki M. Prevalence of Endocervical Chlamydia trachomatis Infection and Related Risk Factors Among Women Attending Gynecology Clinic of Birjand University of Medical Sciences, East of Iran. Arch Clin Infect Dis. 2021;16(2):e110647. [
DOI:10.5812/archcid.110647]
15. Ajani TA, Fayemiwo SA, Oluwasola TAO, Anaedobe CG, Ajani MA, Bakare RA. Prevalence of Asymptomatic genital Chlamydia trachomatis infection among infertile women in Ibadan, Nigeria using Polymerase Chain Reaction. Indian J Med Research and Pharmaceutical Sciences. 2017;4(9):13-23.
16. Mawak JD, Dashe N, Agabi YA, Panshak BW. Prevalence of genital Chlamydia trachomatis infection among Gynaecologic clinic attendees in Jos, Nigeria. Shirez E Med Jl. 2011;12(2):100-106.
17. Sahi AA, Mohammed KA. Comparison of immunological and molecular methods for the detection of Chlamydia trachomatis among infertile women in Basra, Iraq. Ann Trop Med Public Health. 2020;23:232-7. [
DOI:10.36295/ASRO.2020.232237]
18. Shamkhi GJ, Alkhuzai RAH, Al-Shukr NMK. Molecular Genotyping of Chlamydia trachomatis in Iraqi Married Pregnant and Non-Pregnant Women. Arch Razi Inst. 2022;77(2):761-769.
19. Ali, MK, & Shia, JS. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in genitourinary specimens in Iraq women by real time PCR assay. Res J Pharm Biol Chem Sci, 2018;9(6), 799-808.
20. Abdu Alwadood, M. Prevalence rate of chlamydia trachomatis infection in Egyptian infertile women. Al-Azhar J Pharma Sci, 2013;48(2):1-15. [
DOI:10.21608/ajps.2013.7031]
21. Salman YJ, Ahmed ES, Taqi RH. Efficacy of some laboratory samples and techniques in detecting Chlamydia trachomatis infection among women in Kirkuk Province. Int J Curr Res Aca Rev. 2018;6(10):39-50. [
DOI:10.20546/ijcrar.2018.610.005]
22. Ohman H, Tiitinen A, Halttunen M, Lehtinen M, Paavonen J, Surcel HM. Cytokine polymorphisms and severity of tubal damage in women with Chlamydia-associated infertility. J Infect Dis. 2009;199(9):1353-9. [
DOI:10.1086/597620] [
PMID]
23. Salman ST, Khalaf SK, Hussain AA. Infertility rate and relationship between infertility status and microbial infections among women in Baquba city. City.2022;6(S2):1175-86. [
DOI:10.53730/ijhs.v6nS2.5154]
24. Abdella RM, Abdelmoaty HI, Elsherif RH, Sayed AM, Sherif NA, Gouda HM, et al. Screening for Chlamydia trachomatis in Egyptian women with unexplained infertility, comparing real-time PCR techniques to standard serology tests: case control study. BMC Womens Health. 2015;15:45. [
DOI:10.1186/s12905-015-0202-5] [
PMID] [
]
25. Lin W-C, Chang CY-Y, Hsu Y-A, Chiang J-H, Wan L. Increased risk of endometriosis in patients with lower genital tract infection: a nationwide cohort study. Medicine. 2016;95(10) :e2773. [
DOI:10.1097/MD.0000000000002773] [
PMID] [
]
26. Wang C, Tang J, Geisler WM, Crowley-Nowick PA, Wilson CM, Kaslow RA. Human leukocyte antigen and cytokine gene variants as predictors of recurrent Chlamydia trachomatis infection in high-risk adolescents. The Journal of infectious diseases. 2005;191(7):1084-92. [
DOI:10.1086/428592] [
PMID]
27. Rodgers AK, Wang J, Zhang Y, Holden A, Berryhill B, Budrys NM, et al. Association of tubal factor infertility with elevated antibodies to Chlamydia trachomatis caseinolytic protease P. Am J Obstet Gynecol. 2010 Nov;203(5):494.e7-494.e14. [
DOI:10.1016/j.ajog.2010.06.005] [
PMID] [
]
28. Mascellino MT, Boccia P, Oliva A. Immunopathogenesis in Chlamydia trachomatis Infected Women. ISRN Obstet Gynecol. 2011;2011:436936. [
DOI:10.5402/2011/436936] [
PMID] [
]
29. Okpalaji C, Okerengwo A, Okpani A, Chinko B, Bamigbowu E. Serum cytokine concentrations in infertile and fertile women. A preliminary study in port Harcourt, Nigeria. IOSR J Dent Med Sci 2016; 15(9): 77-9. [
DOI:10.9790/0853-1509037779]
30. Kinnunen AH, Surcel HM, Lehtinen M, Karhukorpi J, Tiitinen A, Halttunen M, et al. HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydia trachomatis-related tubal factor infertility: a case-control study. Hum Reprod. 2002;17(8):2073-8. [
DOI:10.1093/humrep/17.8.2073] [
PMID]
31. van Dunné FM, de Craen AJ, Helmerhorst FM, Huizinga TW, Westendorp RG. Interleukin-10 promoter polymorphisms in male and female fertility and fecundity. Genes Immun. 2006;7(8):688-92. [
DOI:10.1038/sj.gene.6364347] [
PMID]
32. Miraghaee SS, Sohrabi M, Jalili C, Bahrehmand F. Assessment of GSTO1 (A140D) and GSTO2 (N142D) Gene Polymorphisms in Iranian Women with Polycystic Ovarian Syndrome. Rep Biochem Mol Biol. 2020;9(1):8-13. [
DOI:10.29252/rbmb.9.1.8] [
PMID] [
]
33. Arcia Franchini AP, Iskander B, Anwer F, Oliveri F, Fotios K, Panday P, Hamid P. The Role of Chlamydia Trachomatis in the Pathogenesis of Cervical Cancer. Cureus. 2022;14(1):e21331. [
DOI:10.7759/cureus.21331]